Skip to NavigationSkip to content

News

Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in FLT3-mutated acute myeloid leukaemia and advanced...
It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore to support the development of...
The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace with the...
It is two and a half years since patients with lung cancer in the US were able to receive Bristol-Myers Squibb’s Opdivo for treatment, the UK has...
The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler. The news follows on shortly from an EMA CHMP...
Venclexta/Venclyxto (venetoclax) successfully met its primary endpoint in Phase 3 trials, providing prolonged, progression-free survival in chronic...
Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal Products for...
Roche's Tecentriq has been added to the list of immunotherapy treatments placed on a partial hold by the FDA over safety concerns.
Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for $1.1 billion...